Role of Corneal Epithelial Thickness during Myopic Regression in Femtosecond Laser-Assisted in Situ Keratomileusis and Transepithelial Photorefractive Keratectomy

DOI: https://doi.org/10.21203/rs.3.rs-1845695/v1

Abstract

Background

The study aimed to investigate the relationship between changes in corneal epithelial thickness and the outcome of myopic regression after femtosecond laser-assisted in situ keratomileusis (FS-LASIK) and transepithelial photorefractive keratectomy (TPRK).

Methods

This study included 45 eyes of 25 patients undergoing FS-LASIK and 44 eyes of 24 patients undergoing TPRK. Myopic regression occurred in these patients postoperatively from 8 to 21 months. The corneal epithelial thickness was measured using a spectral-domain optical coherence tomography at the onset of regression, 3 months after treatment, and 3 months after drug withdrawal.

Results

Compared with that of preoperation, corneal epithelial thickness increased when regression occurred in both groups (all P < 0.05). The thickness of central corneal epithelium in FS-LASIK and TPRK groups reached 65.02 ± 4.12 µm and 61.63 ± 2.91 µm, respectively. The corneal epithelial thickness decreased when myopic regression subsided after 3 months of steroid treatment compared to the onset (P < 0.05). With a decrease in corneal epithelial thickness, the curvature of the anterior corneal surface, central corneal thickness, and refractive power all decreased (all P < 0.05). The corneal epithelial thickness and refractive error remained relatively stable after 3 months of treatment withdrawal (P > 0.05).

Conclusions

The corneal epithelial thickness determined the outcome of myopic regression similarly in FS-LASIK and TPRK. When the corneal epithelium thickened, regression occurred. After steroid treatment, epithelial thickness decreased whereas regression subsided.

Background

Uncorrected myopia is one of the main causes of visual impairment worldwide. Since the 1990s, corneal refractive surgery has become a safe and effective method for correcting myopia, which has a long-term and stable outcome. However, refractive regression after surgery often occurs in patients with high myopia [14]. Previous studies have reported that the rate of regression in high myopic eyes is approximately 30% [5]. Refractive regression affects the predictability, effectiveness, and long-term stability of surgery and is one of the main causes for patients’ dissatisfaction with surgery. In addition to the degree of preoperative refractive error, the occurrence of postoperative regression is related to many factors, such as age, dry eye, the corneal curvature gradient, the thickness of corneal flap, residual stromal bed, and diameter of ablating optical zone [68]. Corneal epithelial hyperplasia, the protruding of corneal posterior surface, corneal stromal reaction, wound healing response, and decreased biomechanical stability may cause refractive regression after surgery, but the exact mechanism of regression remains unclear [9].

Recently, the corneal epithelium has been found to thicken in the laser ablating zone after laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and small-incision lenticule extraction (SMILE), resulting in refractive regression [10, 11]. The degree of epithelial thickening is significantly correlated with the degree of preoperatively myopic correction [12, 13]. The higher the degree of myopic correction, the greater the corneal curvature gradient after surgery and higher the possibility of epithelial thickening. Previous studies have reported that epithelial thickness after LASIK is directly related to the outcome of refractive status [1415]. Topical steroidal agents reducing corneal epithelial thickness were used to reduce refractive regression [16]. It is still unknown whether the change in epithelium thickness following steroid treatment in PRK patients with refractive regression is related to the improvement of refractive state and whether it differs from LASIK model. Furthermore, it is unclear whether refractive regression will occur and whether the epithelium will thicken again after the discontinuation of steroid treatment.

In this prospective study, we investigated the changes of epithelial thickness and refractive status after steroidal treatment in patients with refractive regression after femtosecond LASIK (FS-LASIK) and transepithelial PRK (TPRK). We also examined the changes in the two variables (FS-LASIK and TPRK) after the discontinuation of steroidal treatment.

Subjects And Methods

Study Design and Patients

We conducted a prospective interventional study. Patients with refractive regression during the follow-up after surgery in Qingdao Eye Hospital from October 2019 to January 2021 were enrolled in the study, including 25 patients (45 eyes) undergoing FS-LASIK and 24 patients (44 eyes) undergoing TPRK. The initial surgery occurred from June 2018 to December 2019. This study followed the tenets of the Declaration of Helsinki and was approved by the ethics committee of Qingdao Eye Hospital (Code Number: 2021-02). Informed consent was signed by all patients..

Refractive regression was defined as a myopic shift of 0.5 diopters (D: spherical equivalent) or greater at ≥ 3 months after surgery. An uncorrected distance visual acuity (UDVA) in enrolled patients should have reached 20/20 or more within 3 months after the initial surgery. Exclusion criteria were the following: (1) patients with other ocular diseases, such as glaucoma and dry eye; (2) active inflammation of ocular surface and anterior segment; (3) presence of systemic diseases; (4) under-correction in the initial surgery: (5) myopia caused by lens changes; and (6) iatrogenic corneal ectasia.

Ocular Examination

Before surgery, all patients underwent standard ophthalmic examinations, including UDVA, corrected distance visual acuity (CDVA), cycloplegic and manifest refraction, intraocular pressure, axis length, corneal curvature and thickness, corneal biomechanics using Corvis ST, corneal topography using Pentacam HR (Oculus, Wetzlar, Germany), and corneal epithelial thickness using anterior segment optical coherence tomography (Optovue Inc., Fremont, USA). Each epithelial thickness map covering a 7-mm diameter area was divided into 17 sectors, including a central 2-mm zone and eight octants equally distributed within paracentral (2–5 mm), midperipheral (5–7 mm), and annular zones. The corneal curvature was measured by Pentacam HR to evaluate the changes of corneal refractive power during the follow-up. Each examination was performed by the same experienced and qualified optometrist. The ocular measurements were performed preoperatively, at the beginning of drug treatment, at the end of treatment, and at 3 months after drug withdrawal.

Surgical Procedures And Drug Treatment

All surgeries were performed in the Amaris 750S excimer laser platform with smart pulse technology (Schwind Eye-Tech-Solutions, Germany). The ablation zone was set to 5.9–6.3 mm and a transition zone of 1.5–2.0 mm. In order to prevent the formation of haze in TPRK group, it was recommended to take vitamins c orally and wear ultraviolet protective glasses for a few months after surgery. Patients with regression due to the formation of haze were not enrolled in the study. The enrolled patients were prescribed 0.1% flumirone eye drops (Santen, Tokyo, Japan) four times a day for the first month when refractive regression occurred. Following this, it was reduced to twice a day in the second month and once a day in the third month. The whole treatment lasted for 3 months. When the intraocular pressure increased by more than 5 mm Hg after steroid treatment in few patients, 2% carteolol hydrochloride eye drops were added.

Statistical Analysis

All data were statistically analyzed using IBM SPSS version 26.0 (IBM Inc., New York, USA). The normality of the data was verified with Kolmogorov–Smirnov test. The non-normally distributed data were analyzed with Mann–Whitney test. Continuous variables were expressed in mean and standard deviation. Categorical variables were expressed as percentages. Independent sample t test was used for comparison between the two groups. Paired t test was used for intra-group analysis at different time points. Chi-square or Fischer-exact test was used to compare categorical variables. A P value of less than 0.05 was considered statistically significant.

Results

This study included 25 patients (45 eyes; 7 males and 18 females) with refractive regression in FS-LASIK group and an average age of 29.48 ± 4.90 years (21­–41 years). There were 24 patients (44 eyes; 10 males and 14 females) in TPRK group, with an average age of 26.67 ± 6.42 years (18–39 years). The preoperative spherical equivalent in FS-LASIK and TPRK groups were –7.56 ± 1.01 D and −7.20 ± 1.01 D, respectively. There were significant differences in the cylinderical diopter and corneal thicknesses between the two groups before surgery (< 0.05) and no significant differences in other variables (> 0.05). The postoperative onset time of myopic regression was 11.16 ± 3.18 months (8–21 months) in FS-LASIK group and 11.83 ± 2.70 months (8–19 months) in TPRK group (> 0.05; Table 1).

When refractive regression occurred, the epithelial thickness of the two groups was 65.02 ± 4.12 μm (cET) and 61.63 ± 2.91 μm (mET) in FS-LASIK group and 63.89 ± 3.71 μm (cET), 62.52 ± 2.82 μm (mET), and 54.54 ± 2.23 μm (pET) in TPRK group, which was statistically different from that before surgery (< 0.001; Figure 1A-1D, Table 2). However, the epithelial thickness in the midperipheral zone in FS-LASIK group (52.06 ± 2.97 μm) was not significantly different from that before surgery (= 0.657). The thickness of the central corneal epithelium in both groups was more than 10 μm thicker than that before surgery when regression occurred. The spherical equivalent was −0.92 ± 0.42 D in FS-LASIK group and −0.64 ± 0.14 D in TPRK group (Table 2). The axial length was 26.46 ± 1.04 mm and 26.42 ± 0.96 mm in FS-LASIK and TPRK groups, respectively, which was not different from that before surgery (P > 0.05).

After 3 months of drug treatment, there were significant differences in UDVA, spherical diopter, cylinderical diopter, spherical equivalent, central cornea thickness (CCT), front K1, front K2, and corneal epithelial thickness in three zones compared with the onset of regression (all P < 0.001; Table 2, Figures 2A-2C, Figures 3-4). The thickness of the central corneal epithelium was reduced by approximately 6 μm compared to the onset of regression (Figure 4). There were no significant differences in CDVA, intraocular pressure, axial length, and posterior corneal curvature. At 3 months after drug withdrawal, there were no significant differences in UDVA, CDVA, intraocular pressure, axial length, spherical diopter, cylinderical diopter, spherical equivalent, epithelial thickness, CCT, front K1, and front K2 compared with that after treatment (> 0.05). There was no obvious thickening of corneal epithelium after 3 months of drug withdrawal (Table 2).

Significant differences were seen between the groups in terms of UDVA, sphere, spherical equivalent, CCT, pET, front K1, and front K2 (< 0.05). Although there were no significant differences in cET and mET, there were significant differences in the change rate of epithelial thickness from the center to periphery. It was 12.96 ± 4.03 μm in FS-LASIK group and 9.35 ± 3.65 μm in TPRK group (< 0.001). At 3 months after treatment and 3 months after treatment withdrawal, there were no differences between both groups in epithelial thickness, refractive error, and corneal curvature (> 0.05).

Discussion

It is a common phenomenon for the anterior surface areas flattened by laser ablation to be compensated by epithelial remodeling and thickening to maintain good optical quality of the cornea, after corneal reflective surgery [17, 18]. Variable patterns of epithelial thickening after surgery influence the postoperative refractive status differently [9]. When the epithelial thickening of the central regions exceeds the midperipheral regions, it will increase the optical power in the central regions, which is equivalent to adding a convex lens on the anterior corneal surface; therefore, refractive regression may occur. However, if the epithelial thickening of the midperipheral region exceeds the central regions, resulting in a negative meniscus-like epithelium, it is difficult for refractive regression to occur. Reinstein et al. found that the epithelium of the central regions thickened by 5 µm one month after LASIK for correcting myopia, refractive state drifting to myopia for 0.39 D [19]. The epithelial thickness increased by approximately 6 µm one year after surgery. Kanellopoulos showed that the epithelium thickened by 6 µm in the central regions one year after LASIK for correcting high myopia [20]. However, in the midperipheral regions, it was thickened by approximately 10 µm. Therefore, epithelial thickening does not necessarily cause refractive regression. In this study, epithelial thickening in central regions was more obvious than that in the midperipheral regions when refractive regression occurred.

The pattern of epithelial remodeling and thickening may be different between PRK and LASIK because the mechanism of corneal wound healing is different, and the probability and rate of refractive regression may also be different [21]. Earlier studies have reported that the duration and degree of epithelial thickening in PRK were different from that in LASIK [22]. However, in our previous studies, when correcting high myopia, the postoperative refractive status in FS-LASIK was more likely to drift to myopia than TPRK, which may be related to the more decreased biomechanical stability and more obvious epithelial thickening after FS-LASIK [23]. Kanellopoulos and Asimellis believed that the epithelial thickness was affected not only by the corneal curvature gradient but also by corneal biomechanics after surgery [24, 25]. The epithelial thickening is more obvious in patients with higher myopia and lower corneal thickness [22]. When FS-LASIK and PRK were combined with prophylactic cross-linking, corneal rigidity was strengthened, and the degree of epithelial thickening decreased; thus, the probability of refractive regression was reduced [26, 27].

This study prospectively investigated the postoperative refractive regression after TPRK and FS-LASIK for correcting high myopia. Refractive regression occurred approximately 1 year after surgery in most patients. The epithelial thickness was significantly higher than that before surgery when refractive regression occurred. In FS-LASIK group, the increase in epithelial thickness in the central region was more obvious than that in the midperipheral region, resulting in a greater degree of myopic regression. After 3 months of steroid treatment, the epithelial thickness was relatively lower and the refractive regression was reduced, which means that the occurrence of regression is highly correlated with epithelial thickening. This is similar to Ryu’s study [28]. However, in Ryu’s study, the preoperative epithelial thickness was lacking, and the direct relationship could not be obtained between the change in epithelial thickness and refractive status when regression occurred. Furthermore, due to the combined use of steroid and anti-glaucoma drugs, the corneal posterior surface shape might have been changed. Following this, the change of refractive state was affected. Our study also found that 3 months after drug treatment withdrawal, the refractive status remained relatively stable in most patients. However, regression in a few patients occurred again, accompanied by epithelial thickening and a decrease in visual acuity. Three patients with FS-LASIK needed enhancement surgery, and one patient undergoing TPRK needed surgical retreatment (data not reported). The reason for this difference is not clear. It was speculated that this difference is related to a higher decrease of biomechanical stability after FS-LASIK, suggesting the necessity for combining collagen cross-linking when correcting high myopia, especially in patients with high myopia and lower corneal thickness preoperatively [26, 27].

In addition to corneal epithelial hyperplasia and thickening, various studies consider that refractive regression is related to the protrusion of the posterior surface of the cornea [2931]. Refractive regression can be treated with anti-glaucoma drugs by preventing the protrusion of the posterior surface [32, 33]. During clinical practice, topical steroidal agents and anti-glaucoma drugs were often used together to treat refractive regression, which could bring better therapeutic results because anti-glaucoma drugs could also reduce corneal epithelial thickness [34, 35]. However, in this study, to analyze the sole role of epithelial thickening during refractive regression, anti-glaucoma drugs were not used to prevent the protrusion of the posterior surface. Anti-glaucoma drugs were used in four eyes after the intraocular pressure increased by more than 5 mm Hg during steroid treatment. Meanwhile, we did not find that topical steroidal agents affected the posterior surface of the cornea. Therefore, the use of anti-glaucoma drugs in the four eyes would not affect the accuracy of the conclusions in this study.

There were limitations in our study. No control group not treated with drugs was designed. We could not confirm how long the refractive regression would last and whether it could subside by itself without intervention. In clinical practice, besides enhancement surgery, the main treatment of refractive regression was steroidal agents and anti-glaucoma drugs. For patients with refractive regression affecting visual quality, it was unreasonable not to prescribe drug treatment, which would harm the patients' benefit and cause patients' dissatisfaction. Therefore, in this study, an untreated control group with refractive regression was not designed. Compared with preoperative morphology, the corneal epithelium was indeed thickened with the central regions thickening more, which was different from that without regression in previous study. Furthermore, after steroidal treatment, the epithelium became thinner with the decreasing of curvature in corneal anterior surface, refractive error drifting to positive direction, regression subsiding and other ocular variables remained unchanged. It was enough to verify the purpose of this study, that was, the epithelial thickness played an important role in refractive regression, regardless of what factors leading to changes of epithelial thickness.

Conclusions

In conclusion, this study demonstrated a close correlation between the corneal epithelium and refractive status. When refractive regression occurred, corneal epithelial thickness increased. Visual acuity and refractive status improved after steroid treatment, when epithelial thickness decreased.

Abbreviations

TPRK

transepithelial photorefractive keratectomy

FS-LASIK

femtosecond laser-assisted in situ keratomileusis

UDVA

uncorrected distance visual acuity

CDVA

corrected distance visual acuity

LASIK

laser-assisted in situ keratomileusis

PRK

photorefractive keratectomy

SMILE

small-incision lenticule extraction

UDVA

uncorrected distant visual acuity

CDVA

corrected distance visual acuity

CCT

central cornea thickness

cET

central corneal epithelial thickness

mET

paracentral epithelial thickness

pET

midperipheral epithelial thickness.

Declarations

Ethics approval and consent to participate

The study protocol followed the tenets of the Declaration of Helsinki and was approved by the Ethics Committees of Institutional Review Boards of Qingdao Eye Hospital. All patients were adequately informed about the study as well as the risks and benefits of the surgery and provided signed informed consent to participate.

Consent for publication 

Not applicable.

Availability of data and materials

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors do not have any conflict of interest and have no commercial or proprietary interest in this work.

Funding

This work was supported by the Medical and Health Development Grant of Shandong Province, China (No.2017WS180).

Authors contributions

Study concept and design were performed by LH, WHF and LKL. Data collection was done by LH, ZJF, ST and LKL. Analysis and interpretation of data was done by LH, HQC and LKL. Writing the manuscript were performed by LH, ZJF, WHF and LKL. Critical revision of the manuscript were performed by LH, HQC, ST and LKL. Statistical expertise were performed by LH, HQC and ZJF. Administrative, technical, or material support were performed by LKL. Supervision were performed by LH and LKL. All authors have reviewed the manuscript and approved the final manuscript.

Acknowledgements

Not applicable.

Author details

1 Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, School of Ophthalmology, Shandong First Medical University, Qingdao 266071, Shandong Province, China

2 Department of Ophthalmology, Zaozhuang Municipal Hospital, Zaozhuang 277100, Shandong Province, China

References

  1. Chen YI, Chien KL, Wang IJ, et al. An interval-censored model for predicting myopic regression after laser in situ keratomileusis. Invest Ophthalmol Vis Sci. 2007;48(8):3516-3523.
  2. Albietz JM, Lenton LM, McLennan SG. Chronic dry eye and regression after laser in situ keratomileusis for myopia. J Cataract Refract Surg. 2004;30(3):675-684.
  3. Hu DJ, Feder RS, Basti S, et al. Predictive formula for calculating the probability of LASIK enhancement. J Cataract Refract Surg. 2004;30(2): 363-368.
  4. Dirani M, Couper T, Yau J, et al. Long-term refractive outcomes and stability after excimer laser surgery for myopia. J Cataract Refract Surg. 2010;36(10):1709-1717.
  5. Magallanes R, Shah S, Zadok D, et al. Stability after laser in situ keratomileusis in moderately and extremely myopic eyes. J Cataract Refract Surg. 2001;27(7):1007-1012.
  6. Liu M, Gao H, Shi W. Factors affecting myopic regression after laser in situ keratomileusis and laser-assisted subepithelial keratectomy for high myopia. Seminars in Ophthalmology. 2019;34(5):359-364.
  7. O'Brart DP, Corbett MC, Verma S, et al. Effects of ablation diameter, depth, and edge contour on the outcome of photorefractive keratectomy. J Refract Surg. 1996;12(1):50-60.
  8. O'Brart DP, Gartry DS, Lohmann CP, Muir MG, Marshall J. Excimer laser photorefractive keratectomy for myopia: comparison of 4.00- and 5.00-millimeter ablation zones. J Refract Surg. 1994;10(2):87-94.
  9. Moshirfar M, Desautels JD, Walker BD, Murri MS, Birdsong OC, Hoopes PCS. Mechanisms of optical regression following corneal laser refractive surgery: epithelial and stromal responses. Med Hypothesis Discov Innov Ophthalmol. 2018;7(1):1-9.
  10. Ryu IH, Kim BJ, Lee JH, Kim SW. Comparison of corneal epithelial remodeling after femtosecond laser-assisted LASIK and small incision lenticule extraction (SMILE). J Refract Surg. 2017;33(4):250-256.
  11. Gauthier CA, Holden BA, Epstein D, Tengroth B, Fagerholm P, Hamberg-Nyström H. Role of epithelial hyperplasia in regression following photorefractive keratectomy. Br J Ophthalmol. 1996;80(6):545-548.
  12. Ivarsen A, Fledelius W, Hjortdal JØ. Three-year changes in epithelial and stromal thickness after PRK or LASIK for high myopia. Invest Ophthalmol Vis Sci. 2009;50(5):2061-2066.
  13. Ogasawara K, Onodera T. Residual stromal bed thickness correlates with regression of myopia after LASIK. Clin Ophthalmol. 2016;10:1977-1981.
  14. Salomão MQ, Hofling-Lima AL, Lopes BT, et al. Role of the corneal epithelium measurements in keratorefractive surgery. Curr Opin Ophthalmol. 2017;28(4):326-336.
  15. Gauthier CA, Holden BA, Epstein D, Tengroth B, Fagerholm P, Hamberg-Nyström H. Factors affecting epithelial hyperplasia after photorefractive keratectomy. J Cataract Refract Surg. 1997;23(7):1042-1050.
  16. Fitzsimmons TD, Fagerholm P, Tengroth B. Steroid treatment of myopic regression: acute refractive and topographic changes in excimer photorefractive keratectomy patients.Cornea. 1993;12(4):358-61.
  17. Reinstein DZ, Archer TJ, Gobbe M. Rate of change of curvature of the corneal stromal surface drives epithelial compensatory changes and remodeling. J Refract Surg. 2014;30(12):799-802.
  18. Reinstein DZ, Srivannaboon S, Gobbe M, et al. Epithelial thickness profile changes induced by myopic LASIK as measured by Artemis very high-frequency digital ultrasound. J Refract Surg. 2009;25(5):444-450.
  19. Reinstein DZ, Archer TJ, Gobbe M. Change in epithelial thickness profile 24 hours and longitudinally for 1 year after myopic LASIK: three-dimensional display with Artemis very high-frequency digital ultrasound. J Refract Surg. 2012;28(3):195-201.
  20. Kanellopoulos AJ, Asimellis G. Longitudinal postoperative lasik epithelial thickness profile changes in correlation with degree of myopia correction. J Refract Surg. 2014;30(3):166-171.
  21. Wilson SE, Mohan RR, Hong JW, Lee JS, Choi R, Mohan RR. The wound healing response after laser in situ keratomileusis and photorefractive keratectomy: elusive control of biological variability and effect on custom laser vision correction. Arch Ophthalmol. 2001;119(6):889-896.
  22. Hwang ES, Schallhorn JM, Randleman JB. Utility of regional epithelial thickness measurements in corneal evaluations.Surv Ophthalmol. 2020;65(2):187-204.
  23. Zhang J, Feng Q, Ding W, Peng Y, Long K. Comparison of clinical results between trans-PRK and femtosecond LASIK for correction of high myopia. BMC Ophthalmol. 2020;20(1):243.
  24. Vinciguerra P, Roberts CJ, Albé E, et al. Corneal curvature gradient map: a new corneal topography map to predict the corneal healing process. J Refract Surg. 2014;30(3):202-207.
  25. Kanellopoulos AJ, Aslanides IM, Asimellis G. Correlation between epithelial thickness in normal corneas, untreated ectatic corneas, and ectatic corneas previously treated with CXL: is overall epithelial thickness a very early ectasia prognostic factor? Clin Ophthalmol. 2012;6:789-800.
  26. Kanellopoulos AJ, Asimellis G. Epithelial remodeling after femtosecond laser-assisted high myopic LASIK: comparison of stand-alone with LASIK combined with prophylactic highfluence cross-linking. Cornea. 2014;33(5):463-469.
  27. Kang DSY, Kim SW. Effect of corneal cross-linking on epithelial hyperplasia and myopia regression after transepithelial photorefractive keratectomy. J Refract Surg. 2019;35(6):354-361.
  28. Ryu IH, Kim WK, Nam MS, Kim JK, Kim SW. Reduction of corneal epithelial thickness during medical treatment for myopic regression following FS-LASIK. BMC Ophthalmol. 2020;20(1):296.
  29. Chan TC, Liu D, Yu M, Jhanji V. Longitudinal evaluation of posterior corneal elevation after laser refractive surgery using swept-source optical coherence tomography.Ophthalmology. 2015;122(4):687-692.
  30. Nemet A, Mimouni M, Vainer I, Sela T, Kaiserman I. Factors associated with changes in posterior corneal surface following photorefractive keratectomy.Graefes Arch Clin Exp Ophthalmol. 2021;259(11):3477-3483.
  31. Qi H, Hao Y, Xia Y, Chen Y. Regression-related factors before and after laser in situ keratomileusis.Ophthalmologica. 2006;220(4):272-276.
  32. Shojaei A, Eslani M, Vali Y, Mansouri M, Dadman N, Yaseri M. Effect of timolol on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis: a prospective randomized clinical trial. Am J Ophthalmol. 2012;154(5):790-798.
  33. Kamiya K, Aizawa D, Igarashi A, Komatsu M, Shimizu K. Effects of antiglaucoma drugs on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis. Am J Ophthalmol. 2008;145(2):233-238.
  34. Nam M, Kim SW. Changes in corneal epithelial thickness induced by topical antiglaucoma medications.J Clin Med. 2021;10(16):3464.
  35. Halkiadakis I, Vernikou A, Tzimis V, Markopoulos I, Popeskou K, Konstadinidou V. Assessment of corneal epithelium thickness in glaucomatous patients undergoing medical treatment.J Glaucoma. 2021;30(1):44-49.

Tables

TABLE 1 Comparisons of Ocular Parameters Between FS-LASIK and TPRK Groups Before Surgery (Mean ± SD)

Parameters

FS-LASIK(n=45eyes)

TPRK(n=44 eyes)

P

Age (years) 

29.48±4.90

26.67±6.42

0.090

UDVA (logMAR)

1.29±0.26

1.31±0.31

0.693

CDVA (logMAR)

0.01±0.03

0.01±0.03

0.229

Sphere(D)

-7.07±0.95

-6.86±1.00

0.316

Cylinder(D)

-0.98±0.63

-0.68±0.53

0.017

SE(D)

-7.56±1.01

-7.20±1.01

0.097

IOP (mmHg)

16.67±2.65

15.84±2.68

0.147

Axial length (mm)

26.48±1.03

26.54±0.94

0.756

CCT (μm)

545.69±25.26

523.73±30.61

0.000

OZ (mm)

6.10±0.17

6.06±0.14

0.200

AD (μm)

110.58±12.43

105.93±10.48

0.060

cET(μm)

53.20±1.52

52.98±1.44

0.479

mET (μm) 

52.79±1.53

52.79±1.36

0.976

pET (μm) 

51.84±1.36

52.19±1.22

0.210

KI front (D) 

43.09±1.07

42.93±1.12

0.483

K2 front (D)

44.49±1.37

44.14±1.19

0.198

K1 Back (D)

-6.18±0.20

-6.18±0.21

0.951

K2 Back (D)

-6.61±0.26

-6.59±0.26

0.807

Regression time (months)

11.16±3.18

11.83±2.70

0.788

UDVA = uncorrected distant visual acuity; CDVA = corrected distance visual acuity; SE = spherical equivalent; logMAR = logarithm of the minimum angle of resolution; D =diopters; IOP = intraocular pressure; CCT = central cornea thickness; OZ = optical zone; AD = ablation depth; cET = central corneal epithelial thickness; mET = paracentral epithelial thickness; pET = midperipheral epithelial thickness; K front = anterior corneal curvature; K Back = posterior corneal curvature.


TABLE 2 Changes of Ocular Variables During Regression in FS-LASIK and TPRK Groups Before Treatment, After Treatment and After Drug Withdrawal (Mean ± SD)

 

FS-LASIK (n=45eyes)

TPRK (n=44eyes)

Initial

End

finish

Pa

Pb

Initial

End

finish

Pa

Pb

UDVA (logMAR)

0.15±0.07

0.03±0.06

0.03±0.07

<0.001

0.823

0.11±0.04

-0.02±0.04

-0.02±0.04

<0.001

0.710

CDVA (logMAR)

-0.02±0.03

-0.02±0.04

-0.02±0.03

0.420

0.323

-0.03±0.04

-0.03±0.04

-0.03±0.04

0.083

0.083

Sphere(D)

-0.81±0.42

-0.11±0.36

-0.14±0.39

<0.001

0.291

-0.53±0.13

-0.02±0.19

-0.05±0.20

<0.001

0.400

Cylinder(D)

-0.21±0.17

-0.11±0.16

-0.13±0.26

0.001

0.679

-0.23±0.18

-0.08±0.13

-0.10±0.13

<0.001

0.372

SE(D)

-0.92±0.42

-0.16±0.37

-0.21±0.46

<0.001

0.251

-0.64±0.14

-0.06±0.19

-0.09±0.21

<0.001

0.220

IOP (mmHg)

12.00±2.08

11.82±2.02

11.89±1.71

0.290

0.691

11.95±1.41

11.95±1.63

12.07±1.44

1.000

0.342

Axial length (mm)

26.46±1.02

26.46±1.04

26.46±1.04

0.069

0.719

26.42±0.96

26.42±0.95

26.42±0.95

0.473

0.611

CCT (μm)

444.80±28.40

437.31±28.52

438.38±27.62

<0.001

0.130

414.98±33.05

408.11±34.81

408.93±32.85

<0.001

0.274

cET(μm)

65.02±4.12

59.42±3.70

60.02±4.82

<0.001

0.078

63.89±3.71

58.05±3.98

58.59±3.20

<0.001

0.095

mET (μm) 

61.63±2.91

57.24±3.10

57.55±3.97

<0.001

0.253

62.52±2.82

57.33±2.53

57.67±2.27

<0.001

0.067

pET (μm) 

52.06±2.97

50.86±1.85

51.26±2.14

0.007

0.082

54.54±2.23

51.93±1.24

52.07±1.11

<0.001

0.286

KI front (D) 

37.90±1.10

37.10±1.23

37.14±1.18

<0.001

0.200

37.37±1.41

36.61±1.52

36.64±1.43

<0.001

0.235

K2 front (D)

38.97±1.15

38.07±1.26

38.11±1.27

<0.001

0.140

38.36±1.55

37.63±1.68

37.65±1.40

<0.001

0.790

K1 Back (D)

-6.19±0.21

-6.18±0.20

-6.17±0.20

0.561

0.110

-6.18±0.21

-6.18±0.21

-6.18±0.22

0.352

0.323

K2 Back (D)

-6.57±0.26

-6.59±0.25

-6.58±0.27

0.192

0.200

-6.58±0.25

-6.57±0.25

-6.57±0.25

0.643

0.710

SD = standard deviation; UDVA = uncorrected distant visual acuity; CDVA = corrected distance visual acuity; SE = spherical equivalent; logMAR = logarithm of the minimum angle of resolution; D = diopters; IOP = intraocular pressure; CCT = central cornea thickness; OZ = optical zone; AD = ablation depth; cET = central corneal epithelial thickness; mET = paracentral epithelial thickness; pET = midperipheral epithelial thickness; K front = anterior corneal curvature; K Back = posterior corneal curvature; Initial = before drug treatment; End = three months after drug treatment; Finish = three months after drug withdrawal; compared with before drug treatment; b compared with three months after drug treatment.